AGREEMENTAgreement • November 13th, 2003 • Amylin Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 13th, 2003 Company Industry JurisdictionThis Agreement (“Agreement”) is made effective May 12, 2003, by and between Amylin Pharmaceuticals, Inc., a Delaware corporation having a place of business at 9373 Towne Centre Drive, Suite 250, San Diego, California 92121, USA (“AMYLIN”) and UCB S.A. a Belgium corporation having a place of business at [***] (“UCB”). All references to “AMYLIN” and “UCB” shall include their respective Affiliates.
AMYLIN PHARMACEUTICALS, INC. 2003 NON-EMPLOYEE DIRECTORS’ STOCK OPTION PLAN STOCK OPTION AGREEMENT (NONSTATUTORY STOCK OPTION)Stock Option Agreement • November 13th, 2003 • Amylin Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledNovember 13th, 2003 Company IndustryPursuant to your Stock Option Grant Notice (“Grant Notice”) and this Stock Option Agreement, Amylin Pharmaceuticals, Inc. (the “Company”) has granted you an option pursuant to the Company’s 2003 Non-Employee Directors’ Stock Option Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Options granted under the Plan are issued under the Company’s 2001 Equity Incentive Plan (the “Incentive Plan”), and any shares of the Company’s Common Stock issued upon exercise of your option will be issued out of shares reserved for issuance under the Incentive Plan. Defined terms not explicitly defined in this Stock Option Agreement but defined in the Incentive Plan shall have the same definitions as in the Incentive Plan except to the extent otherwise defined in the Plan.
Amylin Pharmaceuticals, Inc. 2001 Equity Incentive Plan Stock Option Agreement (Incentive Stock Option or Nonstatutory Stock Option)Stock Option Agreement • November 13th, 2003 • Amylin Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledNovember 13th, 2003 Company IndustryPursuant to your Stock Option Grant Notice (“Grant Notice”) and this Stock Option Agreement, Amylin Pharmaceuticals, Inc. (the “Company”) has granted you an option under its 2001 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Stock Option Agreement but defined in the Plan shall have the same definitions as in the Plan.
EMPLOYMENT AGREEMENTEmployment Agreement • November 13th, 2003 • Amylin Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledNovember 13th, 2003 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into effective as of June 9, 2003 (the “Effective Date”), by and between AMYLIN PHARMACEUTICALS, INC., a corporation (the “Company”), and GINGER L. GRAHAM (the “Executive”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”.
CONFIDENTIAL LIMITED MANUFACTURING AND SUPPLY AGREEMENTLimited Manufacturing and Supply Agreement • November 13th, 2003 • Amylin Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledNovember 13th, 2003 Company Industry JurisdictionThis Limited Manufacturing and Supply Agreement (“Agreement”) is effective as of the 16th day of June, 2003 (the “Effective Date”) by and between OMJ Pharmaceuticals, Inc., a New Jersey corporation (“OMJ”), with offices at [***], and Amylin Pharmaceuticals, Inc., a Delaware corporation (“AMYLIN”), with offices at 9373 Towne Centre Drive, Suite 250, San Diego, California 92121.
Amylin Pharmaceuticals, Inc. 2001 Equity Incentive Plan Stock Option Agreement (Incentive Stock Option or Nonstatutory Stock Option)Amylin Pharmaceuticals Inc • November 13th, 2003 • Pharmaceutical preparations
Company FiledNovember 13th, 2003 IndustryPursuant to your Stock Option Grant Notice (“Grant Notice”) and this Stock Option Agreement, Amylin Pharmaceuticals, Inc. (the “Company”) has granted you an option under its 2001 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Stock Option Agreement but defined in the Plan shall have the same definitions as in the Plan.